Sec Form 4 Filing - PYXIS INNOVATIONS INC @ INTERLEUKIN GENETICS INC - 2016-07-29

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person PYXIS INNOVATIONS INC 2. Issuer Name and Ticker or Trading Symbol INTERLEUKIN GENETICS INC [ ILIU] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director X __ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) 7575 FULTON STREET EAST 3. Date of Earliest Transaction (MM/DD/YY) 07/29/2016 (Street) ADA, MI49355-0001 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) _____ Form filed by One Reporting Person __ X __ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 07/29/2016 P 5,030,181 A $ 0.0994 42,595,659 D ( 1 )

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Common Stock Warrant (right to buy) $ 0.0994 07/29/2016 P 5,030,181 07/29/2016 07/29/2023 Common Stock 5,030,181 $ 0 5,030,181 D ( 1 )

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other PYXIS INNOVATIONS INC 7575 FULTON STREET EAST ADA, MI49355-0001 X Alticor Global Holdings Inc. 7575 FULTON STREET EAST ADA, MI49355-0001 X SOLSTICE HOLDINGS INC 7575 FULTON STREET EAST ADA, MI49355-0001 X ALTICOR INC 7575 FULTON STREET EAST ADA, MI49355-0001 X Signatures /s/ Rainey S. Repins, Assistant Secretary 08/03/2016 Signature of Reporting Person Date ALTICOR GLOBAL HOLDINGS INC., /s/ Cheon Kim, Assistant Secretary 08/03/2016 Signature of Reporting Person Date SOLSTICE HOLDINGS INC., /s/ Cheon Kim, Assistant Secretary 08/03/2016 Signature of Reporting Person Date ALTICOR INC., /s/ Cheon Kim, Assistant Secretary 08/03/2016 Signature of Reporting Person Date

Explanation of Responses:

( 1 )The reported securities are owned directly by Pyxis Innovations Inc., which is a wholly owned subsidiary of Alticor Inc., which is a wholly owned subsidiary of Solstice Holdings Inc., which is a wholly owned subsidiary of Alticor Global Holdings Inc. Alticor Inc., Solstice Holdings Inc. and Alticor Global Holdings Inc. are indirect beneficial owners of the reported securities.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.